Creative Planning Acadia Pharmaceuticals Inc Transaction History

Creative Planning

$101 Billion
Q3 2024

A detailed history of Creative Planning transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Creative Planning holds 25,061 shares of ACAD stock, worth $427,791. This represents 0.0% of its overall portfolio holdings.

Number of Shares

25,061

Previous 14,620 71.42%

Holding current value

$427,791

Previous $237,000 62.45%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 11, 2024	BUY	$15.14 - $19.14 $158,076 - $199,840	10,441 Added 71.42%	25,061 $385,000
Q2 2024 Aug 15, 2024	BUY	$14.62 - $18.42 $213,744 - $269,300	14,620 New	14,620 $237,000
Q4 2023 Feb 14, 2024	BUY	$20.78 - $31.77 $150,509 - $230,110	7,243 New	7,243 $226,000
Q3 2022 Nov 03, 2022	SELL	$14.11 - $18.27 $11,429 - $14,798	-810 Reduced 5.78%	13,202 $216,000
Q2 2022 Aug 15, 2022	SELL	$13.01 - $27.22 $88,507 - $185,177	-6,803 Reduced 32.68%	14,012 $197,000
Q1 2022 May 16, 2022	BUY	$20.94 - $27.5 $136,633 - $179,437	6,525 Added 45.66%	20,815 $504,000
Q4 2021 Feb 11, 2022	BUY	$16.79 - $27.09 $5,607 - $9,048	334 Added 2.39%	14,290 $334,000
Q3 2021 Nov 10, 2021	SELL	$15.78 - $24.77 $14,754 - $23,159	-935 Reduced 6.28%	13,956 $232,000
Q2 2021 Aug 04, 2021	SELL	$19.4 - $27.42 $14,355 - $20,290	-740 Reduced 4.73%	14,891 $363,000
Q1 2021 Apr 30, 2021	SELL	$25.02 - $54.99 $353,332 - $776,568	-14,122 Reduced 47.46%	15,631 $403,000
Q4 2020 Jan 29, 2021	BUY	$41.04 - $56.79 $127,429 - $176,332	3,105 Added 11.65%	29,753 $1.59 Million
Q3 2020 Nov 05, 2020	BUY	$36.42 - $57.0 $547,246 - $856,482	15,026 Added 129.29%	26,648 $1.1 Million
Q2 2020 Jul 23, 2020	SELL	$39.26 - $52.73 $82,446 - $110,733	-2,100 Reduced 15.3%	11,622 $563,000
Q1 2020 May 05, 2020	SELL	$31.65 - $46.87 $519,060 - $768,668	-16,400 Reduced 54.45%	13,722 $580,000
Q4 2019 Jan 30, 2020	SELL	$36.21 - $51.4 $109,317 - $155,176	-3,019 Reduced 9.11%	30,122 $1.29 Million
Q3 2019 Nov 01, 2019	SELL	$22.22 - $44.01 $27,219 - $53,912	-1,225 Reduced 3.56%	33,141 $1.19 Million
Q2 2019 Jul 26, 2019	BUY	$23.32 - $28.12 $652 - $787	28 Added 0.08%	34,366 $919,000
Q1 2019 Apr 24, 2019	SELL	$16.17 - $27.38 $21,344 - $36,141	-1,320 Reduced 3.7%	34,338 $922,000
Q4 2018 Feb 01, 2019	BUY	$14.32 - $22.92 $84,144 - $134,677	5,876 Added 19.73%	35,658 $577,000
Q3 2018 Oct 25, 2018	SELL	$13.03 - $21.81 $714,369 - $1.2 Million	-54,825 Reduced 64.8%	29,782 $618,000
Q2 2018 Jul 20, 2018	BUY	$15.07 - $22.34 $181,940 - $269,710	12,073 Added 16.64%	84,607 $1.29 Million
Q1 2018 Apr 18, 2018	BUY	$22.47 - $32.33 $4,943 - $7,112	220 Added 0.3%	72,534 $1.63 Million
Q4 2017 Jan 17, 2018	BUY	$26.84 - $39.14 $657,660 - $959,047	24,503 Added 51.25%	72,314 $2.18 Million
Q3 2017 Oct 17, 2017	BUY	$29.49 - $38.37 $1.41 Million - $1.83 Million	47,811	47,811 $1.8 Million

Others Institutions Holding ACAD

# of Institutions

279

Shares Held

156M

Call Options Held

901K

Put Options Held

314K

View Full List

About ACADIA PHARMACEUTICALS INC

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.76B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

More about ACAD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

News

Stay updated on Creative Planning with notifications on news.

Account

Creative Planning Acadia Pharmaceuticals Inc Transaction History